Navigation Links
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Date:11/5/2009

EMERYVILLE, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a drug discovery and development company focused on the unmet needs in women's health and oncology, today announced third quarter highlights and financial results for the three months ended September 30, 2009.

Subsequent to the end of the quarter, in October 2009, Bionovo successfully completed a public offering and issued approximately 31 million shares of common stock together with approximately 29 million warrants. The net proceeds to the Company were approximately $17.7 million. The Company intends to use these proceeds to conduct a Phase 3 trial of Menerba, its lead product candidate for the treatment of menopausal vasomotor symptoms.

"The third quarter was an extremely productive quarter for Bionovo," stated Isaac Cohen, Bionovo's Chairman and Chief Executive Officer. "Not only did we publish and present a considerable amount of scientific data and make significant progress in the Menerba manufacturing and quality control process, but we also completed an important financing that sets the stage for the next chapter in the history of Bionovo. This financing provides us with the necessary funds to conclude our preparation for the FDA submission and conduct the first of two pivotal clinical trials for Menerba. This is an exciting time at Bionovo, and we eagerly anticipate the accomplishment of important milestones in the upcoming quarters."

Third Quarter 2009 Company Highlights

  • During the third quarter of 2009, Bionovo completed the raw material characterization, analytical method development and pilot manufacturing process development that constitutes a large part of the Chemistry, Manufacturing and Control (CMC) specifications necessary to satisfy the FDA's requests for clarification of the Company's ma
    '/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
3. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
4. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
5. Bionovo Announces First Quarter 2009 Highlights and Financial Results
6. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
7. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
8. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
9. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
10. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
11. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... According to a new market research report ... Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, ... Global Forecasts to 2019 ", published by MarketsandMarkets, the Electrophysiology ... by 2019 with a CAGR of around 10.3% during ... Browse   90   ma rket data T ...
(Date:3/27/2015)... N.J. , March 27, 2015  Johnson & Johnson ... Shareholders at 10 a.m. (Eastern Time) on Thursday, April 23, ... N.J. Investors and other interested parties ... visiting the Company,s website at www.jnj.com and clicking ... from the meeting will be made available a few hours ...
(Date:3/26/2015)... HOUSTON , March 26, 2015  The ... of a study independently conducted by the Department ... Japan have been published. ... compared 5-fluorouracil hepatic arterial infusion as post-operative adjuvant ... colorectal metastasis of the liver. ...
Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... recognition awarded to top-rated abstracts , CAMBRIDGE, Mass., ... the development of novel products to deliver RNAi-based ... that the company,s TransKingdom RNA interference ( tk ... poster sessions featuring late-breaking research at the American ...
... to Evaluate Safety of CCL2-LPM for Inflammatory Kidney ... Inc. announced today that patient dosing has commenced ... company,s lead compound, CCL2-LPM, for the treatment of ... Pharmaceuticals U.S.A. is developing novel chemokine-enzyme fusion protein ...
Cached Medicine Technology:Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research 2Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research 3Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy 2Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy 3
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 How ... is a growing field in orthopaedic medicine. While diagnostic ... tear to confirm the pain etiology, research presented today ... AOSSM ) Specialty Day suggests that pain relief from ... arthroscopic hip surgery. , “Our study looked to ...
(Date:3/28/2015)... 28, 2015 Andrew Hawley of Vintage Rock ... psychedelic concert posters. The Who and the Doors played together ... 2, 1968. According to Hawley, “The Who toured the United ... and college campuses. Perhaps the most famous Who poster was ... and the Doors on August 2, 1968 at the Singer ...
(Date:3/28/2015)... March 28, 2015 The "Petrick ... of sustainable health. After 18 years of research and ... professional UFC contenders, Dr. Jon Petrick is excited to ... Just some of the immediate benefits of this radical ... increased levels of strength of the immune system, faster ...
(Date:3/28/2015)... Robles, CA (PRWEB) March 28, 2015 ... restoration specialists , this week released a report about ... the symptoms of asthma sufferers, and according to recent ... children. , According to the Environmental Protection Agency, ... develop asthmatic reactions. Breathing in mold may trigger asthma ...
(Date:3/27/2015)... Deer, Alberta (PRWEB) March 27, 2015 In ... until then, prevented her from working, Monica K. arrived at ... in the mending department quiet, defensive and scared. The owners ... Placement & Support Services (EPSS) to offer jobs to ... does take patience and a willingness to begin with the ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3
... alternative remedies more likely to misuse prescribed drugs, suffer ... Many asthma patients who use herbal remedies experience increased ... shows. , Researchers followed 326 asthma patients for 33 ... herbal remedies and used prescribed inhaled corticosteroids (ICS) less ...
... , , Wounded Veterans Face Growing ... Feb. 5 Today, Iraq and Afghanistan ... organization representing veterans of the wars in Iraq and ... bureaucratic roadblocks, lengthy waits for care, and complicated disability systems facing ...
... authors are nationally known informatics leaders and members of ... Feb. 2010 issue of Health Affairs and ... delivery in an increasingly information-driven era of health care ... role that information technology, and the health informatics work ...
... ... , ... 5, 2010 -- Aspen Dental ( www.aspendent.com ), one of the largest and fastest-growing providers ... in 2009, opening 44 new dental offices for an expansion of nearly 25 percent. The ...
... children, teens stable longer , THURSDAY, Feb. 4 (HealthDay News) ... type 1 diabetes could benefit by using an artificial pancreas ... levels during sleep and help them control their disease. , ... The Lancet , examined use of an artificial pancreas ...
... ... coronary artery bypass clinical study, based on a protocol reviewed by the U.S. Food ... with the FDA as part of the company,s submission for U.S. regulatory approval of ... (PRWEB) ...
Cached Medicine News:Health News:Herbals Not the Answer for Asthma, Study Shows 2Health News:New IAVA Report Reveals Red Tape Facing Veterans in the Military and VA Health Care and Disability Systems 2Health News:New IAVA Report Reveals Red Tape Facing Veterans in the Military and VA Health Care and Disability Systems 3Health News:New IAVA Report Reveals Red Tape Facing Veterans in the Military and VA Health Care and Disability Systems 4Health News:Informatics experts contribute to special Health Affairs edition on e-health in the developing world 2Health News:Informatics experts contribute to special Health Affairs edition on e-health in the developing world 3Health News:Aspen Dental Opens 44 New Offices, Welcomes 340,000 New Patients in 2009 2Health News:Aspen Dental Opens 44 New Offices, Welcomes 340,000 New Patients in 2009 3Health News:Artificial Pancreas Helps Type 1 Diabetics During Sleep 2Health News:Pluromed Announces Completion of Enrollment in LeGoo™ Cardiac Bypass Clinical Trial 2Health News:Pluromed Announces Completion of Enrollment in LeGoo™ Cardiac Bypass Clinical Trial 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: